Yaomin Du

541 total citations
8 papers, 421 citations indexed

About

Yaomin Du is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Yaomin Du has authored 8 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Nephrology. Recurrent topics in Yaomin Du's work include Renin-Angiotensin System Studies (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Yaomin Du is often cited by papers focused on Renin-Angiotensin System Studies (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Renal Diseases and Glomerulopathies (2 papers). Yaomin Du collaborates with scholars based in China, United States and Australia. Yaomin Du's co-authors include Tianxin Yang, Shufeng Zhou, Yuan Ming Di, Chun Guang Li, Shulin Wu, Eli Chan, Wei Duan, Shu-Feng Zhou, Jiancheng Wang and Min Tian and has published in prestigious journals such as Hypertension, Archives of Biochemistry and Biophysics and American Journal of Physiology-Renal Physiology.

In The Last Decade

Yaomin Du

8 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaomin Du China 8 141 133 81 79 64 8 421
Fang Xia China 6 76 0.5× 101 0.8× 109 1.3× 159 2.0× 46 0.7× 12 420
David J. Kazierad United States 14 166 1.2× 136 1.0× 192 2.4× 103 1.3× 40 0.6× 27 560
Paulo Caleb Júnior Lima Santos Brazil 16 191 1.4× 134 1.0× 100 1.2× 118 1.5× 25 0.4× 34 579
Eva Doleželová Czechia 16 82 0.6× 109 0.8× 65 0.8× 53 0.7× 20 0.3× 26 484
Fariborz A. Yaghini United States 13 130 0.9× 118 0.9× 142 1.8× 76 1.0× 54 0.8× 17 440
Yuanchao Tu China 11 85 0.6× 99 0.7× 75 0.9× 36 0.5× 51 0.8× 14 366
John T. Liles United States 14 108 0.8× 206 1.5× 57 0.7× 62 0.8× 35 0.5× 25 560
El‐Sayed El‐Awady Egypt 6 107 0.8× 126 0.9× 26 0.3× 33 0.4× 35 0.5× 11 444
Krairerk Athirakul United States 7 121 0.9× 141 1.1× 95 1.2× 39 0.5× 152 2.4× 15 467

Countries citing papers authored by Yaomin Du

Since Specialization
Citations

This map shows the geographic impact of Yaomin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaomin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaomin Du more than expected).

Fields of papers citing papers by Yaomin Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaomin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaomin Du. The network helps show where Yaomin Du may publish in the future.

Co-authorship network of co-authors of Yaomin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yaomin Du. A scholar is included among the top collaborators of Yaomin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaomin Du. Yaomin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhao, Liyan, Jie Li, Xiongqing Huang, et al.. (2018). Xyloketal B exerts antihypertensive effect in renovascular hypertensive rats via the NO-sGC-cGMP pathway and calcium signaling. Acta Pharmacologica Sinica. 39(5). 875–884. 15 indexed citations
2.
Wang, Fei, Xiaohan Lu, Kexin Peng, et al.. (2014). Prostaglandin E-Prostanoid 4 Receptor Mediates Angiotensin II–Induced (Pro)Renin Receptor Expression in the Rat Renal Medulla. Hypertension. 64(2). 369–377. 62 indexed citations
3.
Liu, Ying, Zhanjun Jia, Shanshan Liu, et al.. (2013). Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice. American Journal of Physiology-Renal Physiology. 305(11). F1555–F1562. 33 indexed citations
4.
Liu, Shanshan, Zhanjun Jia, Li Zhou, et al.. (2013). Nitro-oleic acid protects against adriamycin-induced nephropathy in mice. American Journal of Physiology-Renal Physiology. 305(11). F1533–F1541. 43 indexed citations
5.
Yang, Tianxin & Yaomin Du. (2012). Distinct Roles of Central and Peripheral Prostaglandin E2 and EP Subtypes in Blood Pressure Regulation. American Journal of Hypertension. 25(10). 1042–1049. 38 indexed citations
6.
Du, Yaomin, et al.. (2009). Activated nuclear factor-κB and increased tumor necrosis factor-α in atrial tissue of atrial fibrillation. Scandinavian Cardiovascular Journal. 43(5). 292–297. 75 indexed citations
7.
Chen, Xiao, Junping Liu, Bee Jen Tan, et al.. (2008). The C-terminus of PRK2/PKNγ is required for optimal activation by RhoA in a GTP-dependent manner. Archives of Biochemistry and Biophysics. 479(2). 170–178. 9 indexed citations
8.
Zhou, Shufeng, Yuan Ming Di, Eli Chan, et al.. (2008). Clinical Pharmacogenetics and Potential Application in Personalized Medicine. Current Drug Metabolism. 9(8). 738–784. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026